The overall goal of the Analytical Genomics and Transgenics Core (AGTC) is to enhance the productivity of the UAB Rheumatic Disease Core Center (RDCC) researchers, and provide state-of-the-art services to facilitate the development and use of appropriate genetic animal models. During the two previous funding cycles, this Core (formerly called the "Gene Targeting Core Facility" (GTCF)) served to support expertise in embryonic stem (ES) cell services as part of the UAB Transgenic Mouse Facility. In response to user needs, the Core has expanded services to more specifically assist with the creation of mouse models relevant to rheumatic disease beyond just ES services to 1) generate novel genetically engineered models of broad utility to multiple RDCC investigators, and 2) establish educational and outreach programs to forge active collaborations between the Core and RDCC investigators, especially in areas related to genomics. Formal educational resources for learning modern and emerging genetic and genomic technologies via workshops, seminars, lectures, and symposia hosted at UAB and our partner institution, Hudson Alpha Institute for Biotechnology (HAIB) are an extension of the core's evolution. The overarching objective and downstream output of the Core remains the same;to produce mouse models of human disease and of human genetic variants contributing to disease in order to provide a mammalian system to study the pathophysiology of rheumatic disease, as well as to test the efficacy of potential treatment interventions. To this end, the Analytical Genomics &Transgenic Core has the following specific aims:
AIM 1. SERVICE: To provide expert services to generate and analyze genetic/genomic data, and to develop translational animal models relating to the mission of the RDCC.
AIM 2. OUTREACH AND EDUCATION: To provide enrichment programs for RDCC investigators.
AIM 3. DEVELOPMENT: To assess RDCC investigator needs and develop new platfonns and technologies to address those needs.
Genetically modified mouse models are critical to the understanding ofthe role of genes, identified genetic variants in humans producing disease, and ultimately creating translational models for developing novel therapeutics. The Analytical Genomics and Transgenics Core (AGTC) has been established to address these needs as they relate to the study of rheumatic disease.
|Pasek, Raymond C; Malarkey, Erik; Berbari, Nicolas F et al. (2016) Coiled-coil domain containing 42 (Ccdc42) is necessary for proper sperm development and male fertility in the mouse. Dev Biol 412:208-18|
|Holt, Leanne Melissa; Olsen, Michelle Lynne (2016) Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System. PLoS One 11:e0150290|
|Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52|
|Pegues, Melissa A; McWilliams, Ian L; Szalai, Alexander J (2016) C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame? Am J Physiol Renal Physiol 311:F176-81|
|Sun, Jim; Schaaf, Kaitlyn; Duverger, Alexandra et al. (2016) Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection. Oncotarget 7:15394-409|
|Yang, Zhenhua; Shah, Kushani; Khodadadi-Jamayran, Alireza et al. (2016) Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells. J Exp Med 213:2349-2364|
|Padgett, Lindsey E; Tse, Hubert M (2016) NADPH Oxidase-Derived Superoxide Provides a Third Signal for CD4 T Cell Effector Responses. J Immunol 197:1733-42|
|Hull, Travis D; Boddu, Ravindra; Guo, Lingling et al. (2016) Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight 1:e85817|
|Jackson, Joshua D; Markert, James M; Li, Li et al. (2016) STAT1 and NF-ÎºB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells. Mol Cancer Res 14:482-92|
|Schultz, Matthew J; Holdbrooks, Andrew T; Chakraborty, Asmi et al. (2016) The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype. Cancer Res 76:3978-88|
Showing the most recent 10 out of 267 publications